Articles with public access mandates - R. Jeffrey LewisLearn more
Available somewhere: 5
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP Investigators
New England Journal of Medicine 385 (9), 790-802, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ...
Jama 324 (13), 1317-1329, 2020
Mandates: US National Institutes of Health, National Health and Medical Research …
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ...
Intensive care medicine 47, 867-886, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations
Trials 22, 1-11, 2021
Mandates: US National Institutes of Health
Development of an evidence-based risk assessment framework
D Krewski, P Saunders-Hastings, RA Baan, TS Barton-Maclaren, ...
Altex 39 (4), 667, 2022
Mandates: US National Institutes of Health, Natural Sciences and Engineering Research …
Publication and funding information is determined automatically by a computer program